Form 4: Zimmer Biomet Executive Wilfred van Zuilen Reports Stock Transactions

Wilfred van Zuilen, Group President, EMEA at Zimmer Biomet, reports the vesting of restricted stock units and subsequent transactions involving common stock.

Summary

• On February 20, 2025, Wilfred van Zuilen, Group President, EMEA at Zimmer Biomet Holdings, Inc., reported transactions involving the company's common stock.
• 2,451 restricted stock units (RSUs) vested, each representing a contingent right to receive one share of Company common stock.
• Van Zuilen acquired 2,451 shares of common stock upon the vesting of these RSUs.
• 645 shares were withheld by Zimmer Biomet to satisfy tax withholding obligations at a price of $103.46 per share.
• Following these transactions, Van Zuilen directly owns 17,941 shares of Zimmer Biomet common stock and 4,901 restricted stock units.
• One-third of the RSUs vested on February 20, 2025, with the remaining RSUs vesting in two equal installments on February 20, 2026, and February 20, 2027.

Sentiment

Score: 5

Explanation: The document is a neutral report of stock transactions, with no inherent positive or negative sentiment.

Future Outlook

The remaining RSUs will vest in two equal installments on February 20, 2026, and February 20, 2027.

Industry Context

This filing is a routine disclosure of insider transactions, which are common in publicly traded companies. It provides transparency into the trading activities of company executives.

Stakeholder Impact

• The transactions have a minor impact on shareholders as they reflect routine executive compensation and tax obligations.

Key Dates